Video

Impact of Provider Status on Health-System Pharmacists

Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.

Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Related Videos
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Related Content
FDA approved oral medication -- Image credit: Anny Art | stock.adobe.com
Published: October 17th 2024 | Updated: October 17th 2024

FDA Approves Sodium Oxybate to Treat Cataplexy or EDS in Pediatric Patients With Narcolepsy

Gillian McGovern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Elderly patient with Parkinson disease -- Image credit: ipopba | stock.adobe.com
Published: October 17th 2024 | Updated: October 17th 2024

FDA Approves Foscarbidopa/Foslevodopa for Motor Fluctuations in Adults With Parkinson Disease

Gillian McGovern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Safe Travels Post-Transplant: Navigating Travel Risks and Appropriate Guidelines
October 17th 2024

Safe Travels Post-Transplant: Navigating Travel Risks and Appropriate Guidelines

Alana Hippensteele, Managing Editor
Semaglutide injecting pen on a white background, macro. Needle macro - Image credit: artmim | stock.adobe.com
October 17th 2024

Concerns Linger About GLP-1 Inhibitors Despite Their Popularity

Jeannette Y. Wick, RPh, MBA, FASCP